Apart from elevated expression of neuronal markers, we also observed reduction in expression of NFκB and IκB genes in the drug-treated AD-Neuro cells (Figure 5e), suggesting suppression of inflammatory pathway. This evidence concerns the gene NFKB1 and Alzheimer disease.